Filters
reset allOther countries
Results: 1 to 12 of 12
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
MYO3A - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
MYO3A - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 288 | 218 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics United States | 356 | 211 |
|
Deafness, Autosomal Recessive 30 (DFNB30) via the MYO3A Gene PreventionGenetics United States | 1 | 1 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Nonsyndromic Hearing Loss NGS Panel Fulgent Genetics United States | 146 | 99 |
|
Hearing Loss Advanced Sequencing and CNV Evaluation Athena Diagnostics Inc United States | 249 | 184 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Hereditary Hearing Loss-Common and Non-Syndromic Hearing Loss Panel Genome Diagnostics Laboratory The Hospital for Sick Children Canada | 64 | 57 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.